Multi-Biomarker Profiling for Precision Diagnosis of Lung Cancer

Area of Science:

• Biomarker Discovery
• Cancer Diagnostics
• Spectroscopy

Background:

• Multi-biomarker analysis improves diagnostic accuracy over single biomarkers by mitigating genetic and environmental variability.
• Conventional methods for multi-biomarker analysis are hindered by lengthy pre-processing, inconsistent outcomes, and substantial sample volume needs.

Purpose of the Study:

• To introduce a rapid and precise diagnostic method for lung cancer detection using multi-biomarker profiling from a small blood sample.
• To address the limitations of traditional multi-biomarker analysis techniques.

Main Methods:

• Surface-enhanced Raman spectroscopic immunoassay (SERSIA) was utilized for rapid and reliable quantification of multiple biomarkers in blood serum.
• Statistical analysis was performed to determine the correlation between multi-biomarker profiles and the differentiation of healthy individuals from lung cancer patients.

Main Results:

• Lung cancer was diagnosed with 92% accuracy using only 20 µL of blood serum.
• The method achieved 87% accuracy in identifying cancer type and 85% accuracy in determining cancer stage.
• The study demonstrated the effectiveness of multi-biomarker analysis in overcoming single-biomarker diagnostic challenges.

Conclusions:

• The developed SERSIA-based multi-biomarker approach significantly enhances clinical diagnostics for lung cancer.
• This method offers a promising advancement in precision diagnostics, improving upon existing multi-biomarker analysis techniques.